Application of Real-time Ultrasound Guidance in Thoracic Epidural Catheter Placement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-23

Study Completion Date

2027-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to assess the success rate of real-time ultrasound-guided thoracic epidural catheter placement at the first attempt in patients who will undergo thoracic or abdominal surgeries. The main aims are to:

Assess the success rate of first-attempt thoracic epidural catheter placement. Assess the procedure duration of real-time ultrasound-guided epidural catheter placement Participants will be managed according to the following protocol The patient will have real-time ultrasound guided catheter placement using paramedian-cross view performed by an attending anesthesiologist who is also an investigator After being secured, the thoracic epidural catheter is tested with 3ml lidocaine 2% At 30 minutes after the test dose, the level of sensory block is assessed by using an ice cube to test cold sensation on the skin according to dermatome Epidural analgesia is initiated by a 0.1ml/kg bolus and maintained by continuous infusion of solution 0.1% ropivacaine combined with 1mcg/ml fentanyl during the surgery At the end of the surgery, the patients will paracetamol 15miligram per kilogram and nefopam 20 milligrams, the patient will receive another epidural bolus dose of 0,1ml/kg ropivacaine 0.1% combined with fentanyl 1mcg/ml After the surgery, the patient will receive paracetamol 15miligram per kilogram every 8 hours, nefopam 20mg every eight hours, continuous epidural infusion at rate 4-8 ml per hour, patient-controlled analgesia morphine 1mg bolus, lockout 15 minutes, maximum 4mg per hour. Additional bolus dose of 4ml ropivacaine 0.1% will be administered every 30 min if VAS pain score at rest exceed 4. After two top-up bolus doses of 4ml ropivacaine 0.1% , if VAS pain score at rest still exceed 4, the patient will receive 2mg morphine every 15 minutes until VAS score less than 4 The patient will be monitored for vital signs, pain scores, the level of sensory block, opioids consumption, pain site, other adverse effect of opioids such as respiratory depression, sedation. The patient is also monitored for other signs and symptoms associated with nerve injuries or epidural hematoma such severe back pain, radicular pain, numbness, loss of sensation below the level of epidural catheter placement, paralysis or limb motor weakness.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Utilizing Ultrasound for Residents as an Aid in Epidural Placement

NCT03378492

Epidural Placement

WITHDRAWN NA

Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique

NCT02271100

Labor Pain

COMPLETED NA

A Factorial Trial of Ultrasound and Manometry to Improve the Success of Thoracic Epidural Placement

NCT03559023

Surgery

UNKNOWN NA

Ultrasound-Guided Technique for Thoracic Epidural Insertion

NCT01449214

Pain

COMPLETED NA

Ultrasound Needle Transducer for Regional Anesthesia Validation Study

NCT04726930

Thorax; Pain, Spine, With Radicular and Visceral Pain Acute Post-thoracotomy Pain Pain, Postoperative +1 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The consecutive sampling method is used in this clinical trial. Patients who meet inclusion criteria and consent to participate will be recruited Real-time ultrasound-guided epidural placement is performed by an attending anesthesiologists on participants using a paramedian-cross view to approach to the thoracic epidural space.

The process of real-time ultrasound-guided epidural catheter placement is described in detail in the following procedure.

Patient is placed in the prone position with continuous monitoring and oxygen supplementation via nasal cannula. A thin pillow is placed under the upper abdomen. After establishing an adequately sterilized field , the anesthesiologist places curvilinear probe on the 12th rib, then move cranially, until the rib below the target interlaminar space is reached. Then, probe is slid medially to identify anatomical structures: costotransverse joint, transverse process, lamina, superior articular process. Once consecutive laminas and superior articular processes are identified, the probe is the rotated clockwise toward the midline to visualize key ultrasound images from caudal to cranial positions: the lower transverse process, the lamina, the targeted interspace between the lower lamina and base of the upper spinal process. Then, 2ml of 1% lidocaine is administered to numb the anticipated skin puncture site. After that, 18G Tuohy needle is advanced under ultrasound guidance from inferior to superior aiming for the interspace between the lamina and base of the upper spinal process. Since the tip of Tuohy needle reaches the interspace between the lamina and base of the upper spinal process, the anesthesiologist performs a loss-of-resistance test using 0.9% saline to identify the thoracic epidural space. After achieving positive loss-of- resistance test, a catheter is advanced 4-5 cm into the epidural space. Finally, a test dose of 3 ml of 2% lidocaine is administered via the catheter.

At 30 minutes after the test dose, the level of sensory block is assessed by using an ice cube to test cold sensation on the skin. The evaluation will be conducted by an anesthesiologist or an anesthesia nurse. The cold sensation in the thoracic-abdominal dermatomes will be compared to the cold sensation in the shoulder or the ipsilateral arm and any reduction in cold perception in the tested dermatomes will be documented.

After having thoracic epidural catheter placement, the patient undergoes general anesthesia with routine monitoring. Intraoperative management is conducted by another attending anesthesiologist who doesn't participate in the study. After general anesthesia induction and patient positioning, the epidural catheter is activated with a bolus dose of 0.1 ml per kilogram solution of 0.1% ropivacaine + fentanyl 2mcg/ml. Vital signs are monitored every 5 minutes following epidural activation and for 15 minutes after surgical incision.

During the surgery, general anesthesia is maintained with sevoflurane or desflurane at MAC 1-1.2, along with continuous neuromuscular agent infusion to achieve TOF 0-1.The solution containing 0.1% ropivacaine and fentanyl 2mcg/ml at rate 4-8ml per hour is infused continuously via the epidural catheter. An additional intravenous bolus dose of fentanyl 1mcg/kg is administered if heart rate and blood pressure exceed 20% of baseline levels.

Before the completion of surgery, multimodal analgesia is initiated with intravenous paracetamol (15mg/kg) and nefopam (20mg). Additionally, a bolus dose of 0.1ml/kg of local anesthetic solution 0.1% ropivacaine combined with 2mcg/ml fentanyl is administered via the epidural catheter for postoperative pain control.

After surgery, patients will receive multimodal analgesia, including intravenous paracetamol 15 milligrams per kilogram and nefopam 20 milligrams every 8 hours. Epidural analgesia is maintained with a continuous infusion of 0.1% ropivacaine at a rate of 4-8 ml per hour, along with patient-controlled analgesia (PCA) morphine bolus dose of 1 milligram, with a 15-minute lockout interval and a maximum dose of 4 mg per hour.

Patients are monitored for vital signs, level of sensory blockade, pain scores using the Visual Analog Scale (VAS) at rest and during coughing, reported pain location, opioid consumption at specific time points 2, 8, 16, 24, and 48 hours postoperatively. If VAS pain scores at rest exceed 4, a top-up bolus of 4ml of 0.1% ropivacaine is administered via the epidural catheter. Vital signs, pain scores and the level of sensory block are monitored every 15 minutes following the rescue dose. A second 4ml 0.1% ropivacaine bolus can be administered 30 minutes after the first bolus. 30 minutes after the second, if the VAS score at rest still exceeds 4, a rescue 2mg morphine bolus every 15 minutes is administered until the VAS score is less than 4.

The epidural catheter is removed 48 hours after the surgery, provided there are no signs of severe back pain , neurological deficits, hypotension associated with epidural infusion, catheter dislodgement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

First-attempt Success Rate of Real-time Ultrasound-guided Thoracic Epidural Catheter Placement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

real-time ultrasound guided thoracic epidural catheter placement

Group Type EXPERIMENTAL

Real-time ultrasound-guided thoracic epidural placement

Intervention Type PROCEDURE

Real-time ultrasound-guided thoracic epidural catheter placement is performed by an attending anesthesiologist using paramedian-cross view to approach thoracic epidural space.

The patient is placed in the prone position with a pillow under the upper abdomen. The probe is placed to identify the rib, then moved medially to identify key anatomical structures: costotransverse joint, transverse process, lamina, superior articular process. The probe is rotated clockwise toward the midline to visualize the lamina and base of the spinal process.

A 18G Tuohy needle is advanced under ultrasound guidance from inferior to superior aiming for the interspace between the lamina and base of the upper spinal process.

After the tip of Tuohy needle approaches the interspace, the anesthesiologist will perform a loss-of-resistance test to identify the epidural space. Then a catheter will be inserted into epidural space.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Real-time ultrasound-guided thoracic epidural placement

Real-time ultrasound-guided thoracic epidural catheter placement is performed by an attending anesthesiologist using paramedian-cross view to approach thoracic epidural space.

The patient is placed in the prone position with a pillow under the upper abdomen. The probe is placed to identify the rib, then moved medially to identify key anatomical structures: costotransverse joint, transverse process, lamina, superior articular process. The probe is rotated clockwise toward the midline to visualize the lamina and base of the spinal process.

A 18G Tuohy needle is advanced under ultrasound guidance from inferior to superior aiming for the interspace between the lamina and base of the upper spinal process.

After the tip of Tuohy needle approaches the interspace, the anesthesiologist will perform a loss-of-resistance test to identify the epidural space. Then a catheter will be inserted into epidural space.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients are scheduled for major thoracic or abdominal surgeries who have consented to thoracic epidural analgesia

Exclusion Criteria

* Patients have contraindications for central neuraxial analgesia, allergic to medications used in the study, unable to cooperate due to cognitive impairment or behavioral limitations, spinal deformities or other spinal pathologies.

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No